close
MENU
Hot Topic NBR Focus: GMO
Hot Topic NBR Focus: GMO
Investment
3 mins to read

Comvita to reduce costs a further $10m on ‘prolonged weakness’

Listed honey company has reduced 2024 earnings guidance and says 2025 target very unlikely to be met.

NBR Staff Mon, 20 May 2024

NZX-listed honey and wellness business Comvita will look to remove a further $10 million in costs in the 2025 financial year after “prolonged weakness” in demand saw it reduce guidance for the next two years.

The company, which in February said it had received an indicative, non-binding

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

NZ$399.00 / yearly

Offer ends July 31st

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
NBR Staff Mon, 20 May 2024
Contact the Writer: editor@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Company profile
Powered by: nzx logo
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low
Comvita to reduce costs a further $10m on ‘prolonged weakness’
Investment,
104113
true